Featured Articles

  1. Improving Rare Disease Recruitment With Data And AI 4/15/2026

    Finding patients for rare disease clinical trials can be an uphill battle; fortunately, there are ways sponsors can address the most common stumbling blocks in the recruitment process.

  2. Pharma R&D Annual Review Supplement: New Active Substances 4/15/2026

    Last year was by some distance the best year ever in terms of new active substances. Explore the 105 new debuts that easily outstrips that of the previous record holder, 2021’s, 97.

  3. Sol-Gel Builds Awareness Of Rare Skin Condition, Generates Leads 4/1/2026

    Explore a 60-day HCP Awareness email campaign that surpassed industry benchmarks and generated a substantial number of leads.

  4. Sneak Peek Of Pharma R&D Annual Review 3/23/2026

    Drug development experts remain intent on pharma’s prospects, especially in China, which have overtaken the US in first-time new drugs and continues to nurture a robust pipeline.

  5. Best Practices In Rare Disease Patient Recruitment 3/9/2026

    Recruiting for rare disease clinical trials is daunting, and making patients aware of clinical trials, involving them in trial design, and building trust are a few ways sponsors can boost recruitment.

  6. SCOPE 2026 In The Rear-View Mirror 2/18/2026

    Another SCOPE Summit is in the record books, and it was jam-packed with informative sessions. Themes included patient-centricity, AI (no surprise here), patient recruitment, and much more.

  7. Biopharma Reaping Numerous Benefits From AI 2/18/2026

    Multiple AI use cases with significant impact have been identified, and they are expected to drive innovations in clinical trials, precision medicine, and commercial operations.

  8. Predictions For 2026 In Life Sciences 1/15/2026

    Experts predict 2026 trends: more pragmatic trial design, expanded use of data and AI for patient matching, and registration and reporting of results for all human trials.

  9. Decision-Ready Data Restores Clinical Teams' Confidence 1/14/2026

    The data underlying strategic decisions made by clinical teams often remain fragmented, backward-looking, or insufficiently validated. These teams need decision-ready data that brings clarity where it matters most.

  10. No More Swiss Holes: Filling The Gaps In Clinical Trial Disclosure 1/14/2026

    This use case shows how sponsors can gain clarity on disclosure requirements when entering a new country.